Clinical trial / 2011
Goji berry supplementation protected macular characteristics and raised antioxidant levels in older adults.
In a randomized, double-blind, placebo-controlled trial, 150 healthy adults aged 65 to 70 received either 13.7 g/day of a goji berry formulation (n = 75) or placebo (n = 75) for 90 days. The placebo group showed macular hypopigmentation and soft drusen accumulation, whereas the supplemented group remained stable. Goji berry supplementation also increased plasma zeaxanthin by 26% and antioxidant capacity by 57%, with no product-related adverse events.
- Study type
- Randomized controlled trial
- Who was studied
- 150 healthy older adults (aged 65–70 years)
- What was measured
- Macular pigmentation, drusen accumulation, and plasma antioxidant levels
THE PAPER
Goji berry effects on macular characteristics and plasma antioxidant levels.
Bucheli P, Vidal K, Shen L, Gu Z, Zhang C, Miller LE, Wang J. Optom Vis Sci, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.